Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityNo recent work listed

Bo Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-2899-0434; OpenAlex author ID A5100335416. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2020: 3 papers

Papers 3

  1. A novel derivative of valepotriate inhibits the PI3K/AKT pathway and causes Noxa-dependent apoptosis in human pancreatic cancer cells. Last author DOI 10.1038/s41401-019-0354-1↗
  2. The Ibr-7 derivative of ibrutinib radiosensitizes pancreatic cancer cells by downregulating p-EGFR. Co-author DOI 10.1186/s12935-020-01548-6↗
  3. A New Fusion Peptide Targeting Pancreatic Cancer and Inhibiting Tumor Growth. First author DOI 10.2147/ott.s246969↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Youyou Yan · 2 shared papers, 2020 · strength 0.24
  2. Fei Wang · 1 shared paper, 2020 · strength 0.13
  3. Nengming Lin · 1 shared paper, 2020 · strength 0.13
  4. Biqin Tan · 1 shared paper, 2020 · strength 0.13
  5. Rong Dong · 1 shared paper, 2020 · strength 0.13
  6. Xiaoman He · 1 shared paper, 2020 · strength 0.12
  7. Lei Zheng · 1 shared paper, 2020 · strength 0.12
  8. Jing Chen · 1 shared paper, 2020 · strength 0.12
  9. Nengming Lin · 1 shared paper, 2020 · strength 0.12
  10. Yulian Wu · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.